Bohuslav Melichar
0000-0002-5474-6866
Publication & Citation Trends
Publications
0 total
2603P Final analysis of lenvatinib + pembrolizumab (L+P) vs sunitinib (S) in patients with advanced renal cell carcinoma (aRCC) with or without bone metastases in CLEAR
Cited by 0
Semantic Scholar
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 OA
Cited by 3
Semantic Scholar
2607P Belzutifan for advanced clear cell renal cell carcinoma (ccRCC) after a PD-(L)1 inhibitor and ≥2 VEGFR-TKIs in LITESPARK-005
Cited by 0
Semantic Scholar
2326P Systemic therapy of muscle-invasive urothelial cancer in the Czech Republic: The value of the MDT approach and referral to comprehensive oncology centres
Cited by 0
Semantic Scholar
LBA74 Final analysis of the phase III LITESPARK-005 study of belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC)
Cited by 9
Semantic Scholar
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
Cited by 25
Semantic Scholar
1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma
Cited by 6
Semantic Scholar
941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)
Cited by 0
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(161)
Cancer Immunotherapy and Biomarkers
(92)
Cancer Genomics and Diagnostics
(90)
Pancreatic and Hepatic Oncology Research
(67)
Renal and related cancers
(67)
Affiliations
Université Paris-Sud
Roche (Switzerland)
University of Verona
Novartis (Switzerland)
European Union